Today, Genome Biology has published research describing crops genetically modified using genome editing technology. The researchers use CRISPR/Cas9 on both barley and Brassica, and here we ask the authors more about their findings.
As we hail CRISPR/Cas as the most versatile, easy to design genome editing tool, as CRISPR in every form and color wins media attention, it is very easy to forget that the true workhorse in this system is an unimposing enzyme: Cas9.
‘Big Data’ is becoming increasingly ubiquitous in our lives, and we at GigaScience are big fans of approaches democratizing its utility through crowdfunding and crowdsourcing.
After helping promote community genome and microbiome projects such as the Puerto Rican “peoples parrot”, Azolla Genome, Kittybiome, and the community cactus, we’ve finally decided to launch our own.
Here’s a roundup of some of the latest research published in our biology journals during October.
The tropical zebrafish (Danio rerio) is a popular aquarium fish, yet it is also an important vertebrate model organism in scientific research for studying developmental processes and human diseases.
Today, Genome Biology published research investigating the success of using zinc-finger nucleases to create attenuated parasites for use in a vaccine. Here, co-authors Friedrich Frischknecht and Mirko Singer answer our questions.
Modifying plant genomes is still a challenge despite the recent advances in technology. Research published in Genome Biology set to develop more efficient methods, showing that they can be applied to an important crop species. I asked co-author Tomáš Čermák to explain more.
The updated wheat genome sequence, released today, is a new step toward generating improved wheat varieties. Here, Genome Biology‘s Dominique Morneau outlines the challenges and opportunities that accompany the sequencing of the wheat genome.
Research published in Biology of Sex Differences today investigates the sex differences in opioid addiction in Canada. Here co-authors Monica Bawor and Zena Samaan reveal more about their research, including how women may be more susceptible to addiction.
With epigenetics being known to play a major role in some diseases, we’re now seeing the emergence of specialist centers dedicated to clinical epigenetics research. In this Q&A, Dr Hans T Bjornsson gives an insight into the exciting work going on at his Johns Hopkins patient clinic.